BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Thomas RM, Ruel E, Shantavasinkul PC, Corsino L. Endocrine hypertension: An overview on the current etiopathogenesis and management options. World J Hypertens 2015; 5(2): 14-27 [PMID: 26413481 DOI: 10.5494/wjh.v5.i2.14]
URL: https://www.wjgnet.com/2220-3168/full/v5/i2/14.htm
Number Citing Articles
1
Aleksandra Huljić, Aleksandra Caričić, Bojan Pavković, Marija Zarić, Bojan Prokić, Milica Kuljanin. Pheochromocytoma as a cause of secondary arterial hypertensionTimocki medicinski glasnik 2018; 43(1): 22 doi: 10.5937/tmg1801022H
2
Wei Wang, Feng Wei, RanHao Li, JiaHui Tian. A case report of idiopathic hyperaldosteronism characterized by bilateral adrenal adenomaMedicine 2019; 98(43): e17418 doi: 10.1097/MD.0000000000017418
3
Francisco Bandeira, Morgana Barbosa Duarte, Ana Maíra Quental da Nóbrega. Endocrinology and Diabetes2022; : 103 doi: 10.1007/978-3-030-90684-9_11
4
V. O. Shuper, S. V. Shuper, I. V. Trefanenko, H. I. Shumko, T. V. Reva . Pharmacotherapeutic Features of the Management of Patients with Secondary Arterial Hypertension of Endocrine GenesisUkraïnsʹkij žurnal medicini, bìologìï ta sportu 2022; 7(4): 122 doi: 10.26693/jmbs07.04.122
5
Filippo Ceccato, Marco Boscaro. Cushing’s Syndrome: Screening and DiagnosisHigh Blood Pressure & Cardiovascular Prevention 2016; 23(3): 209 doi: 10.1007/s40292-016-0153-4
6
I. A. Vaychulis, I. I. Shaposhnik. The Main Provisions of the International Recommendations on Detection of Endocrine HypertensionKardiologiia 2019; 59(10): 88 doi: 10.18087/cardio.2019.10.2669
7
Sai Sudha Mannemuddhu, Ian Macumber, Joshua A. Samuels, Joseph T. Flynn, Andrew M. South. When Hypertension Grows Up: Implications for Transitioning Care of Adolescents and Young Adults With Hypertension From Pediatric to Adult Health Care ProvidersAdvances in Chronic Kidney Disease 2022; 29(3): 263 doi: 10.1053/j.ackd.2021.11.005
8
María del Mar Rodríguez Rodríguez, Lucía Jiménez Mendiguchía, Marta Rosillo Coronado, Ana García Cano. Diagnóstico diferencial del hiperaldosteronismo primarioRevista del Laboratorio Clínico 2017; 10(3): 148 doi: 10.1016/j.labcli.2017.02.002
9
William G. La Cava, Paul C. Lee, Imran Ajmal, Xiruo Ding, Priyanka Solanki, Jordana B. Cohen, Jason H. Moore, Daniel S. Herman. A flexible symbolic regression method for constructing interpretable clinical prediction modelsnpj Digital Medicine 2023; 6(1) doi: 10.1038/s41746-023-00833-8
10
Iuri Martin Goemann, Ana Luiza Maia. Endocrine Hypertension2023; : 149 doi: 10.1016/B978-0-323-96120-2.00003-0
11
Agata Buonacera, Benedetta Stancanelli, Lorenzo Malatino. Endocrine Tumors Causing Arterial Hypertension: Pathophysiological Mechanisms and Clinical ImplicationsHigh Blood Pressure & Cardiovascular Prevention 2017; 24(3): 217 doi: 10.1007/s40292-017-0200-9
12
Natividad Pons Fernández, Francisca Moreno, Julia Morata, Ana Moriano, Sara León, Carmen De Mingo, Ángel Zuñiga, Fernando Calvo. Familial hyperaldosteronism type III a novel case and review of literatureReviews in Endocrine and Metabolic Disorders 2019; 20(1): 27 doi: 10.1007/s11154-018-9481-0
13
Irina Benenson, Frederick Waldron, Molly Bradshaw, Tracy Vitale. Endocrine Hypertension: A Primer for Primary Care Nurse PractitionersThe Journal for Nurse Practitioners 2019; 15(10): 782 doi: 10.1016/j.nurpra.2019.08.028
14
Joseph M. Pappachan, Harit N. Buch. Hypertension: from basic research to clinical practiceAdvances in Experimental Medicine and Biology 2016; 956: 215 doi: 10.1007/5584_2016_26
15
Stanley M. Chen Cardenas, Prasanna Santhanam. 11C-metomidate PET in the diagnosis of adrenal masses and primary aldosteronism: a review of the literatureEndocrine 2020; 70(3): 479 doi: 10.1007/s12020-020-02474-3
16
Jia-Yuh Sheu, Shuo-Meng Wang, Vin-Cent Wu, Kuo-How Huang, Chi-Shin Tseng, Yuan-Ju Lee, Yao-Chou Tsai, Yen-Hung Lin, Jeff S. Chueh. Estimated glomerular filtration rate-dip after medical target therapy associated with increased mortality and cardiovascular events in patients with primary aldosteronismJournal of Hypertension 2023; 41(9): 1401 doi: 10.1097/HJH.0000000000003479
17
Bogdan-Sorin Tudurachi, Laura Țăpoi, Delia Lidia Şalaru, Laura Cătălina Benchea, Carmen Elena Pleșoianu, Radu Andy Sascău, Cristian Stǎtescu. Endocrine Hypertension – a Multifaceted DiseaseRomanian Journal of Cardiology 2022; 32(2): 120 doi: 10.2478/rjc-2022-0017
18
Jeongmin Lee, Jeonghoon Ha, Sang-Kuon Lee, Hye Lim Park, Sung-Hoon Kim, Dong-Jun Lim, Jung Min Lee, Sang-Ah Chang, Moo Il Kang, Min-Hee Kim. Feasibility of Iodine-131 6β-Methyl-Iodo-19 Norcholesterol (NP-59) Scintigraphy to Complement Adrenal Venous Sampling in Management of Primary Aldosteronism: A Case SeriesInternational Journal of General Medicine 2021; : 673 doi: 10.2147/IJGM.S288774
19
Ilkay Cakir, Serkan Senol, Yasin Simsek, Zuleyha Karaca, Kursad Unluhizarci, Fatih Tanrıverdi. Primary hyperaldosteronism presenting with rhabdomyolysis in emergency room – Case reportJournal of Acute Disease 2016; 5(3): 264 doi: 10.1016/j.joad.2016.03.020
20
Tarun Saxena, Azeema Ozefa Ali, Manjari Saxena. Pathophysiology of essential hypertension: an updateExpert Review of Cardiovascular Therapy 2018; 16(12): 879 doi: 10.1080/14779072.2018.1540301
21
Eleni P. Kotanidou, Styliani Giza, Vasiliki-Regina Tsinopoulou, Maria Vogiatzi, Assimina Galli-Tsinopoulou. Diagnosis and Management of Endocrine Hypertension in Children and AdolescentsCurrent Pharmaceutical Design 2020; 26(43): 5591 doi: 10.2174/1381612826666201113103614
22
Mohammed Azfar Siddiqui, Pardeep K. Mittal, Brent P. Little, Frank H. Miller, Ece Isin Akduman, Kamran Ali, Sara Sartaj, Courtney C. Moreno. Secondary Hypertension and Complications: Diagnosis and Role of ImagingRadioGraphics 2019; 39(4): 1036 doi: 10.1148/rg.2019180184
23
Ernest E. Lack, Edina Paal. Urologic Surgical Pathology2020; : 902 doi: 10.1016/B978-0-323-54941-7.00016-5
24
Anand Kumar Mishra, Kulranjan Singh, Pooja Ramakant, Amit Agarwal. Evidence-Based Endocrine Surgery2018; : 377 doi: 10.1007/978-981-10-1124-5_28